C5a車 The c5a peptide is a pivotal molecule within the body's intricate defense system, the complement system. This potent peptide, also known as complement component 5a, anaphylatoxin C5a, or peptide C5a, serves as an integral component of the complement system.作者:A Klos·2013·被引用次数:355—These fragments, C5a, C4a, and C3a,participate at all levels of the immune responseand are also involved in other processes such as neural ... Its primary functions revolve around orchestrating inflammatory responses and facilitating the elimination of pathogens. The c5a peptide is generated through the cleavage of complement component C5 by the enzyme C5 convertase, resulting in two fragments: C5a and C5b. Specifically, C5a emerges as a powerful mediator of inflammation, playing a critical role in both pathogen clearance and immunomodulation.Our frozen, irradiated AequoZen cells express a variety of GPCRs which all couple to a calcium response.
The significance of the c5a peptide in biological processes is underscored by its classification as an extremely potent proinflammatory peptide. This potency stems from its ability to bind to specific receptors on various immune cells. The primary receptor for C5a is C5a receptor 1 (C5aR1), also known as C5a1 or CD88. This binding event triggers a cascade of cellular responses, including chemotaxis, degranulation of leukocytes, and increased vascular permeability. Consequently, C5a is a plasma protein involved in cellular inflammatory processes by inducing these critical immune cell activities. Its role extends to being a potent chemotactic factor for neutrophils and other leukocytes, effectively directing these cells to sites of infection or injury.
Beyond its inflammatory functions, the c5a peptide also possesses potent spasmogenic and chemotactic activity. This means it can induce smooth muscle contraction and attract immune cells to specific locations.C5a receptor This combined activity makes C5a a key player in acute inflammatory responses and a crucial factor in the recruitment of immune cells to combat infections. The molecule's influence is so profound that it is described as participating at all levels of the immune response.
The research surrounding the c5a peptide highlights its involvement in a wide array of physiological and pathological conditions.C5a is a potent chemoattractant and anaphylatoxinthat acts on all classes of leukocytes and on many other cell types including endothelial, smooth muscle, ... For instance, C5a receptor 1 modulates inflammatory responses, obesity, development and cancersC5a1 is the specific receptor for the chemotactic and inflammatory peptide anaphylatoxin C5a. Receptor activation stimulates chemotaxis, granule enzyme release, .... Studies have also indicated that C5a is crucial to triggering cellular immune responses, and its overexpression is implicated in conditions such as arthritis, Alzheimer's disease, and cystic fibrosis. This broad impact makes C5a a significant target for therapeutic interventions aimed at managing inflammatory and autoimmune diseases.
The structural characteristics of the c5a peptide are also noteworthy. In humans, it is typically an ~11 kDa, 74 amino acid glycoprotein. This structure allows it to interact effectively with its receptors. It is described as a single, non-glycosylated, polypeptide chain containing 74 amino acids when produced recombinantly in E. coli, with a molecular mass of 8.3kDa. In its native form, however, Human C5a is an ~11 kDa, 74 amino acid glycoprotein released from the alpha-chain of C5 by C5 convertase enzymesC5a受體- 維基百科,自由的百科全書. The N-linked glycosylation is not essential for its activity. Furthermore, C5a is composed of alpha and beta polypeptide chains, which are linked by a disulfide bridge作者:A Klos·2013·被引用次数:355—These fragments, C5a, C4a, and C3a,participate at all levels of the immune responseand are also involved in other processes such as neural .... There is also a naturally occurring form known as Complement C5a des-Arg, Human, which is a native, single chain glycopeptide of 73 amino acids, formed upon removal of the C-terminal arginine from C5a.
The therapeutic potential of targeting the c5a peptide pathway is an active area of research. This involves developing molecules that can block the action of C5a or its receptors. For example, research is exploring designer antibody-like peptides for targeting the C5a receptorC5a, Human, Recombinant. These approaches aim to mitigate the detrimental effects of excessive C5a activity in various diseases. The development of synthetic human and mouse C5a also aids in understanding its mechanisms and exploring therapeutic strategies. Inhibitors of C5 have already found applications in treating glomerular diseases, demonstrating the clinical relevance of targeting this pathwayRecombinant Mouse Complement C5A Protein-Biosimilar .... The identification of a potent and orally active non-peptide C5a receptor antagonist further underscores the ongoing efforts to develop effective treatments.
In summary, the c5a peptide is a multifaceted and essential component of the immune system. Its role as a potent inflammatory mediator, chemoattractant, and anaphylatoxin makes it critical for pathogen clearance and immunomodulation. While indispensable for a healthy immune response, dysregulation of C5a activity can contribute to various inflammatory and autoimmune conditions, making it a key target for therapeutic developmentC5a Human Recombinant produced in E.Coli isa single, non-glycosylated, polypeptide chain containing 74 amino acidsand having a molecular mass of 8.3kDa.. The ongoing research into C5a receptor agonists and antagonists, as well as the study of C5a receptor 1 and its interaction with C5aR1 and C5aR2, continues to shed light on the complex biology of this vital peptide.
Join the newsletter to receive news, updates, new products and freebies in your inbox.